메뉴 건너뛰기




Volumn 14, Issue 4 II, 2000, Pages 421-426

Mycophenolate mofetil, with cyclosporine and prednisone, reduces early rejection while allowing the use of less antilymphocytic agent induction and cyclosporine in renal recipients with delayed graft function

Author keywords

Antilymphocytic agent induction; Cyclosporine; Immunosuppression; Kidney transplantation; Mycophenolate mofetil; Rejection

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THYMOCYTE ANTIBODY;

EID: 0033916569     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2000.14041102.x     Document Type: Article
Times cited : (12)

References (35)
  • 23
    • 0029115531 scopus 로고
    • Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group
    • (1995) Transplantation , vol.15 , pp. 225
    • Sollinger, H.W.1
  • 27
    • 0008579188 scopus 로고    scopus 로고
    • SPSS Incorporated, Chicago IL.
  • 29
    • 0008606887 scopus 로고
    • Roche laboratories. CellCept (mycohenolate mofetil capsules). Hoffmann-La Roche Incorporated.
    • (1995)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.